Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCKBR | P32239 | 3/20 | 0.37 |
| ▸ | HPGD | P15428 | 1/20 | 0.37 |
| ▸ | OPRM1 | P35372 | 3/20 | 0.37 |
| ▸ | OPRD1 | P41143 | 3/20 | 0.37 |
| ▸ | OPRK1 | P41145 | 3/20 | 0.37 |
| ▸ | POLB | P06746 | 3/20 | 0.35 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.35 |
| ▸ | RAB9A | P51151 | 1/20 | 0.35 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | PTGDR2 | Q9Y5Y4 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | PKM | P14618 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10185544 | 0.85 | OPRM1 (0.40) | OPRM1OPRD1OPRK1POLBMAPK1 | |
| SCHEMBL10183666 | 0.85 | OPRM1 (0.39) | OPRM1OPRD1OPRK1POLBMAPK1 | |
| SCHEMBL10185926 | 0.85 | OPRM1 (0.39) | OPRM1OPRD1OPRK1POLBMAPK1 | |
| SCHEMBL10183767 | 0.84 | OPRM1 (0.39) | OPRM1OPRD1OPRK1POLBMAPK1 | |
| SCHEMBL10183904 | 0.78 | OPRM1 (0.38) | HPGDOPRM1OPRD1OPRK1POLB | |
| SCHEMBL10183975 | 0.78 | POLB (0.37) | HPGDOPRM1OPRD1OPRK1POLB | |
| SCHEMBL10184095 | 0.77 | TP53 (0.41) | OPRM1OPRD1OPRK1 | |
| SCHEMBL10184153 | 0.75 | OPRM1 (0.39) | HPGDOPRM1OPRD1OPRK1POLB | |
| SCHEMBL10185945 | 0.75 | OPRM1 (0.39) | CCKBROPRM1OPRD1OPRK1POLB | |
| SCHEMBL10184154 | 0.74 | POLB (0.39) | CCKBROPRM1OPRD1OPRK1POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2012009678-A1 | THERAPEUTICALLY ACTIVE COMPOSITIONS AND THEIR METHOD OF USE | AGIOS PHARMACEUTICALS, INC. (US) | 2012-01-19 | — | — | WO | disclosed |